S&P 500   4,005.45 (+0.64%)
DOW   31,752.19 (+0.54%)
QQQ   300.79 (+0.61%)
AAPL   155.72 (-0.15%)
MSFT   259.56 (+0.57%)
META   161.51 (+0.70%)
GOOGL   109.33 (-0.11%)
AMZN   129.81 (+0.25%)
TSLA   287.70 (+1.41%)
NVDA   138.73 (+1.16%)
NIO   17.58 (+0.57%)
BABA   90.09 (-0.56%)
AMD   82.47 (+3.59%)
T   16.86 (-0.06%)
MU   55.12 (+0.22%)
CGC   3.42 (+0.29%)
F   15.23 (-1.30%)
GE   73.69 (+0.15%)
DIS   112.78 (+0.08%)
AMC   8.57 (+2.15%)
PYPL   96.02 (+1.11%)
PFE   46.71 (+1.26%)
NFLX   227.65 (-0.57%)
S&P 500   4,005.45 (+0.64%)
DOW   31,752.19 (+0.54%)
QQQ   300.79 (+0.61%)
AAPL   155.72 (-0.15%)
MSFT   259.56 (+0.57%)
META   161.51 (+0.70%)
GOOGL   109.33 (-0.11%)
AMZN   129.81 (+0.25%)
TSLA   287.70 (+1.41%)
NVDA   138.73 (+1.16%)
NIO   17.58 (+0.57%)
BABA   90.09 (-0.56%)
AMD   82.47 (+3.59%)
T   16.86 (-0.06%)
MU   55.12 (+0.22%)
CGC   3.42 (+0.29%)
F   15.23 (-1.30%)
GE   73.69 (+0.15%)
DIS   112.78 (+0.08%)
AMC   8.57 (+2.15%)
PYPL   96.02 (+1.11%)
PFE   46.71 (+1.26%)
NFLX   227.65 (-0.57%)
S&P 500   4,005.45 (+0.64%)
DOW   31,752.19 (+0.54%)
QQQ   300.79 (+0.61%)
AAPL   155.72 (-0.15%)
MSFT   259.56 (+0.57%)
META   161.51 (+0.70%)
GOOGL   109.33 (-0.11%)
AMZN   129.81 (+0.25%)
TSLA   287.70 (+1.41%)
NVDA   138.73 (+1.16%)
NIO   17.58 (+0.57%)
BABA   90.09 (-0.56%)
AMD   82.47 (+3.59%)
T   16.86 (-0.06%)
MU   55.12 (+0.22%)
CGC   3.42 (+0.29%)
F   15.23 (-1.30%)
GE   73.69 (+0.15%)
DIS   112.78 (+0.08%)
AMC   8.57 (+2.15%)
PYPL   96.02 (+1.11%)
PFE   46.71 (+1.26%)
NFLX   227.65 (-0.57%)
S&P 500   4,005.45 (+0.64%)
DOW   31,752.19 (+0.54%)
QQQ   300.79 (+0.61%)
AAPL   155.72 (-0.15%)
MSFT   259.56 (+0.57%)
META   161.51 (+0.70%)
GOOGL   109.33 (-0.11%)
AMZN   129.81 (+0.25%)
TSLA   287.70 (+1.41%)
NVDA   138.73 (+1.16%)
NIO   17.58 (+0.57%)
BABA   90.09 (-0.56%)
AMD   82.47 (+3.59%)
T   16.86 (-0.06%)
MU   55.12 (+0.22%)
CGC   3.42 (+0.29%)
F   15.23 (-1.30%)
GE   73.69 (+0.15%)
DIS   112.78 (+0.08%)
AMC   8.57 (+2.15%)
PYPL   96.02 (+1.11%)
PFE   46.71 (+1.26%)
NFLX   227.65 (-0.57%)
NASDAQ:CDLX

Cardlytics - CDLX Price Target & Analyst Ratings

$11.89
-0.67 (-5.33%)
(As of 09/8/2022 10:56 AM ET)
Add
Compare
Today's Range
$11.25
$11.89
50-Day Range
$11.77
$23.54
52-Week Range
$11.27
$97.34
Volume
4,263 shs
Average Volume
426,298 shs
Market Capitalization
$391.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.40

Cardlytics Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 5 Analyst Ratings

Consensus Analyst Price Target

$20.20
69.89% Upside
High Prediction$35.00
Average Prediction$20.20
Low Prediction$13.00
TypeCurrent
9/8/21 to 9/8/22
1 Month Ago
8/9/21 to 8/9/22
3 Months Ago
6/10/21 to 6/10/22
1 Year Ago
9/8/20 to 9/8/21
Consensus Rating
Hold
Hold
Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
Hold
2 Hold rating(s)
3 Hold rating(s)
0 Hold rating(s)
3 Hold rating(s)
Sell
2 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$20.20$20.40$60.67$133.00
Predicted Upside69.89% Upside17.93% Upside22.38% Upside12.19% Upside
Get Cardlytics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter.


CDLX Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CDLX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cardlytics Stock vs. The Competition

TypeCardlyticsBusiness Services CompaniesS&P 500
Consensus Rating Score
2.00
2.60
2.49
Consensus RatingHoldBuyHold
Predicted Upside62.42% Upside178.63% Upside21.72% Upside
News Sentiment RatingPositive News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
207
58.31%
Underperform Votes
148
41.69%
Avg. Outperform Votes
173
64.07%
Avg. Underperform Votes
97
35.93%
Avg. Outperform Votes
851
68.46%
Avg. Underperform Votes
392
31.54%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/8/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeEqual Weight ➝ Underweight$14.00 ➝ $13.00+3.50%
8/3/2022Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kyle Peterson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy$24.00 ➝ $19.00+26.08%
7/12/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underperform$14.00-10.43%
7/12/2022Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$50.00 ➝ $20.00+20.88%
6/29/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$47.00 ➝ $35.00+44.75%
3/1/2021Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$90.00 ➝ $150.00+6.17%
1/14/2021William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Shutler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
7/9/2020SunTrust Banks
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetPositive ➝ Buy$55.00 ➝ $75.00+6.64%
1/15/2020Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
(Data available from 9/8/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












CDLX Price Target - Frequently Asked Questions

What is Cardlytics's consensus rating and price target?

According to the issued ratings of 5 analysts in the last year, the consensus rating for Cardlytics stock is Hold based on the current 2 sell ratings, 2 hold ratings and 1 buy rating for CDLX. The average twelve-month price prediction for Cardlytics is $20.20 with a high price target of $35.00 and a low price target of $13.00. Learn more on CDLX's analyst rating history.

Do Wall Street analysts like Cardlytics more than its competitors?

Analysts like Cardlytics less than other Business Services companies. The consensus rating for Cardlytics is Hold while the average consensus rating for business services companies is Buy. Learn more on how CDLX compares to other companies.

Do MarketBeat users like Cardlytics more than its competitors?

MarketBeat users like Cardlytics less than other Business Services companies. 58.15% of MarketBeat users gave Cardlytics an outperform vote while business services companies recieve an average of 64.07% outperform votes by MarketBeat users.

Is Cardlytics being downgraded by Wall Street analysts?

Over the previous 90 days, Cardlytics's stock had 4 downgrades by analysts.

Does Cardlytics's stock price have much upside?

According to analysts, Cardlytics's stock has a predicted upside of 20.26% based on their 12-month price targets.

What analysts cover Cardlytics?

Cardlytics has been rated by Bank of America, Craig Hallum, JPMorgan Chase & Co., Needham & Company LLC, and Wells Fargo & Company in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:CDLX) was last updated on 9/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.